Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

UBL4A Mouse anti-Human, Clone: OTI4B6, liquid, TrueMAB™ Non-distribution product as customer accommodation.

Mouse Monoclonal Antibody

Manufacturer:  OriGeneSupplier Diversity Partner TA502471

Catalog No. 50-167-3524


Add to cart

Description

Description

UBL4A is a component of the BAT3 complex, a multiprotein complex involved in the post-translational delivery of tail-anchored (TA) membrane proteins to the endoplasmic reticulum membrane. UBL4A is the TA membrane proteins, also named type II transmembrane proteins, contain a single C-terminal transmembrane region. The complex acts by facilitating TA proteins capture by ASNA1/TRC40: it is recruited to ribosomes synthesizing membrane proteins, interacts with the transmembrane region of newly released TA proteins, and transfers them to ASNA1/TRC40 for targeting.
Specifications

Specifications

UBL4A
Monoclonal
0.19 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
P11441
DX254E, DXS254E, G6PD, GDX, GET5, MDY2, TMA24, UBL4
Mouse
IgG2a
100 μL
-20° C, Avoid Freeze/Thaw Cycles
Primary
8266
Immunocytochemistry, Immunofluorescence, Western Blot
OTI4B6
Unconjugated
UBL4A
Liquid
UBL4A
Full length human recombit protein of human UBL4A produced in E.coli.
Affinity Chromatography
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit